IRIS Accounts Production v25.3.0.601 16005628 Board of Directors 8.10.24 30.6.25 30.6.25 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 16005628 2024-10-07 16005628 2025-06-30 16005628 2024-10-08 2025-06-30 16005628 2024-10-07 16005628 ns15:EnglandWales 2024-10-08 2025-06-30 16005628 ns14:PoundSterling 2024-10-08 2025-06-30 16005628 ns10:Director1 2024-10-08 2025-06-30 16005628 ns10:PrivateLimitedCompanyLtd 2024-10-08 2025-06-30 16005628 ns10:SmallEntities 2024-10-08 2025-06-30 16005628 ns10:AuditExempt-NoAccountantsReport 2024-10-08 2025-06-30 16005628 ns10:SmallCompaniesRegimeForDirectorsReport 2024-10-08 2025-06-30 16005628 ns10:SmallCompaniesRegimeForAccounts 2024-10-08 2025-06-30 16005628 ns10:AbridgedAccounts 2024-10-08 2025-06-30 16005628 ns10:Director2 2024-10-08 2025-06-30 16005628 ns10:RegisteredOffice 2024-10-08 2025-06-30 16005628 ns5:CurrentFinancialInstruments 2025-06-30 16005628 ns5:ShareCapital 2025-06-30 16005628 ns5:RetainedEarningsAccumulatedLosses 2025-06-30

REGISTERED NUMBER: 16005628 (England and Wales)

Gap Medical Group Limited

Unaudited Financial Statements for the Period 8 October 2024 to 30 June 2025

Gap Medical Group Limited (Registered number: 16005628)

Contents of the Financial Statements

for the Period 8 October 2024 to 30 June 2025

Page |

Company Information | 1 |

Abridged Statement of Financial Position | 2 |

Notes to the Financial Statements | 3 |

Gap Medical Group Limited

Company Information

for the Period 8 October 2024 to 30 June 2025

| DIRECTORS: | Mrs A J Smith

| A C Smith

| REGISTERED OFFICE: | 4 King Square

| Bridgwater

| Somerset

| TA6 3YF

| REGISTERED NUMBER: | 16005628 (England and Wales)

| ACCOUNTANTS: | Maxwells

| Chartered Accountants

| 4 King Square

| Bridgwater

| Somerset

| TA6 3YF

| BANKERS: | Revolut Ltd

| 7 Westferry Circus

| Canary Wharf

| London

| E14 4HD

Gap Medical Group Limited (Registered number: 16005628)

Abridged Statement of Financial Position

30 June 2025

| Notes | £ | £ |

| FIXED ASSETS

| Investments | 5 | 571 |  |

| CURRENT ASSETS

| Cash at bank | 7,836 |  |  |

| CREDITORS

| Amounts falling due within one year | 8,877 |  |

| NET CURRENT LIABILITIES | (1,041 | ) |

| TOTAL ASSETS LESS CURRENT LIABILITIES | (470 | ) |

| CAPITAL AND RESERVES

| Called up share capital | 170 |  |

| Retained earnings | (640 | ) |

| SHAREHOLDERS' FUNDS | (470 | ) |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 June 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Statement of Financial Position for the period ended 30 June 2025 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 November 2025 and were signed on its behalf by:

A C Smith - Director

Gap Medical Group Limited (Registered number: 16005628)

Notes to the Financial Statements

for the Period 8 October 2024 to 30 June 2025

1. | STATUTORY INFORMATION

| Gap Medical Group Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | STATEMENT OF COMPLIANCE

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| The financial statements have been prepared under the historical cost convention.

| The financial statements have been prepared on a going concern basis which assumes the continued

| support of the company’s directors.

| Preparation of consolidated financial statements

| The financial statements contain information about Gap Medical Group Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

| Investments in subsidiaries

| Investments in subsidiary undertakings are recognised at cost.

| Taxation

| Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

4. | EMPLOYEES AND DIRECTORS

| The average number of employees during the period was 2 .

Gap Medical Group Limited (Registered number: 16005628)

Notes to the Financial Statements - continued

for the Period 8 October 2024 to 30 June 2025

5. | FIXED ASSET INVESTMENTS

| Information on investments other than loans is as follows:

| Totals

£ |

| COST

| Additions | 571 |  |

| At 30 June 2025 | 571 |  |

| NET BOOK VALUE

| At 30 June 2025 | 571 |  |